Chemed EPS - Earnings per Share 2010-2024 | CHE
Chemed annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Chemed EPS for the quarter ending March 31, 2024 was $4.24, a 18.44% increase year-over-year.
- Chemed EPS for the twelve months ending March 31, 2024 was $18.59, a 16.99% increase year-over-year.
- Chemed 2023 annual EPS was $17.93, a 8.47% increase from 2022.
- Chemed 2022 annual EPS was $16.53, a 1.9% decline from 2021.
- Chemed 2021 annual EPS was $16.85, a 13.5% decline from 2020.
| Chemed Annual EPS |
| 2023 |
$17.93 |
| 2022 |
$16.53 |
| 2021 |
$16.85 |
| 2020 |
$19.48 |
| 2019 |
$13.31 |
| 2018 |
$12.23 |
| 2017 |
$5.86 |
| 2016 |
$6.48 |
| 2015 |
$6.33 |
| 2014 |
$5.57 |
| 2013 |
$4.16 |
| 2012 |
$4.62 |
| 2011 |
$4.10 |
| 2010 |
$3.55 |
| 2009 |
$3.24 |
| Chemed Quarterly EPS |
| 2024-03-31 |
$4.24 |
| 2023-12-31 |
$5.91 |
| 2023-09-30 |
$4.93 |
| 2023-06-30 |
$3.51 |
| 2023-03-31 |
$3.58 |
| 2022-12-31 |
$4.13 |
| 2022-09-30 |
$3.78 |
| 2022-06-30 |
$4.40 |
| 2022-03-31 |
$4.22 |
| 2021-12-31 |
$4.78 |
| 2021-09-30 |
$4.55 |
| 2021-06-30 |
$3.51 |
| 2021-03-31 |
$4.01 |
| 2020-12-31 |
$6.95 |
| 2020-09-30 |
$4.14 |
| 2020-06-30 |
$5.01 |
| 2020-03-31 |
$3.38 |
| 2019-12-31 |
$3.97 |
| 2019-09-30 |
$3.56 |
| 2019-06-30 |
$3.08 |
| 2019-03-31 |
$2.70 |
| 2018-12-31 |
$3.24 |
| 2018-09-30 |
$3.06 |
| 2018-06-30 |
$3.27 |
| 2018-03-31 |
$2.66 |
| 2017-12-31 |
$3.30 |
| 2017-09-30 |
$2.13 |
| 2017-06-30 |
$-1.35 |
| 2017-03-31 |
$1.78 |
| 2016-12-31 |
$1.93 |
| 2016-09-30 |
$1.62 |
| 2016-06-30 |
$1.48 |
| 2016-03-31 |
$1.45 |
| 2015-12-31 |
$1.73 |
| 2015-09-30 |
$1.65 |
| 2015-06-30 |
$1.55 |
| 2015-03-31 |
$1.40 |
| 2014-12-31 |
$1.70 |
| 2014-09-30 |
$1.39 |
| 2014-06-30 |
$1.36 |
| 2014-03-31 |
$1.12 |
| 2013-12-31 |
$1.28 |
| 2013-09-30 |
$0.94 |
| 2013-06-30 |
$0.77 |
| 2013-03-31 |
$1.17 |
| 2012-12-31 |
$1.39 |
| 2012-09-30 |
$1.07 |
| 2012-06-30 |
$1.10 |
| 2012-03-31 |
$1.06 |
| 2011-12-31 |
$1.28 |
| 2011-09-30 |
$1.04 |
| 2011-06-30 |
$0.94 |
| 2011-03-31 |
$0.84 |
| 2010-12-31 |
$0.98 |
| 2010-09-30 |
$0.91 |
| 2010-06-30 |
$0.82 |
| 2010-03-31 |
$0.84 |
| 2009-12-31 |
$0.79 |
| 2009-09-30 |
$0.84 |
| 2009-06-30 |
$0.76 |
| 2009-03-31 |
$0.85 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$8.472B |
$2.264B |
|
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
|
